液相色谱-串联质谱法同时测定生物组织全基因组DNA甲基化和羟甲基化水平

测定全基因组DNA甲基化和羟甲基化水平对于研究环境污染物暴露的影响及致病机理具有重要的作用。本文建立了液相色谱-串联质谱（LC-MS/MS）同时测定动物组织中全基因组DNA甲基化和羟甲基化水平的方法。从动物组织样品中提取DNA,并将其酶解成单核苷,利用液相色谱-串联质谱法测定5-甲基胞嘧啶核苷、5-羟甲基胞嘧啶核苷和鸟嘌呤核苷的含量,计算全基因组DNA甲基化率和羟甲基化率。利用该方法研究了砷暴露对大鼠肝脏和小脑全基因组DNA甲基化和羟甲基化水平的影响,得到了砷影响DNA甲基化及羟甲基化的初步数据。该方法具有良好的重现性、灵敏度和稳定性,可以同时检测差异较大的DNA甲基化和羟甲基化水平。为同时研究DNA甲基化和羟甲基化水平提供了有力的支持。     

亲水作用色谱法测定组织中全基因组DNA甲基化水平

建立了亲水作用色谱(HILIC)测定组织中全基因组DNA甲基化水平的方法。采用苯酚-氯仿提取组织中的DNA,提取的DNA用88%甲酸在140 ℃下裂解,经N2吹干后,加乙腈-水(9:1, v/v)溶解,用Waters BEH HILIC柱进行分离,在277 nm波长下检测胞嘧啶(Cyt)及5-甲基胞嘧啶(5-mCyt)含量。结果表明,以乙腈-10 mmol/L甲酸铵溶液(94:6, v/v)为流动相,流速为0.5 mL/min, Cyt与5-mCyt分离较好,保留时间分别为2.6与3.1 min。胞嘧啶的线性范围为1～900 μmol/L,相关系数为0.9999; 5-甲基胞嘧啶的线性范围为1～64 μmol/L,相关系数为0.9998。胞嘧啶和5-甲基胞嘧啶的检出限为54 nmol/L(柱中为0.54 pmol),定量限为250 nmol/L(柱中为2.5 pmol);在5～900 μmol/L的添加水平下,胞嘧啶和5-甲基胞嘧啶的平均加标回收率为94.7%～100.5%,相对标准偏差小于1.48%。用该方法检测了结肠癌组织中DNA甲基化水平,结果显示该癌组织中全基因组的DNA甲基化均值为4.0%。该方法快速、简单,稳定性好,灵敏度较高,能满足全基因组DNA甲基化的检测要求。     

人体结肠癌组织样品中基因组DNA甲基化水平的HPLC—ESI MS／MS检测

利用多重监测反应模式(MRM),通过对液相色谱及质谱条件的优化,建立了人体结肠癌组织样品中基因组DNA甲基化的高效液相色谱-电喷雾质谱(HPLC-ESI MS/MS)检测方法,对结肠癌组织及癌旁组织中基因组DNA甲基化进行了检测.结果表明,5-甲基脱氧胞苷(5mdC)的检出限是1 pg,线性范围为0.037 5～0.5 mg/L,工作曲线相关系数大于0.999 0,该方法的相对标准偏差为2.32%～9.21%.结肠癌病人样品检测结果表明,结肠癌组织基因组DNA甲基化水平低于相应的癌旁组织(P<0.05).     

基于高效液相色谱的喹啉类药物对刺参DNA甲基化水平的影响研究

建立了高效液相色谱/紫外法测定刺参组织全基因组DNA甲基化水平的方法,并运用此方法对喹噁啉药物处理过的刺参样品DNA甲基化水平进行分析。色谱条件为:色谱柱为ZORBAX SB-Aq(4.6 mm×250mm;5μm);柱温为30℃;检测波长为280 nm;进样量20μL;流动相为甲醇-7 mmol/L乙酸铵(7∶93),流速为1.0 mL/min。5-甲基脱氧胞苷和脱氧胞苷的质量浓度在0.05~1.0 mg/L范围内时,线性关系良好,相关系数(r)均为0.999 9。5-甲基脱氧胞苷和脱氧胞苷的检出限均为0.05 mg/L,在加标浓度为0.05,0.25,1.0 mg/L时,回收率为90.4%~100.6%,批内、批间相对标准偏差均小于4%。采用CTAB法提取刺参组织DNA,酶解后进行HPLC测定,结果表明:喹噁啉药物处理过的组织样品DNA甲基化水平低于对照组,该类药物通过改变DNA甲基化水平而影响基因的正常表达,可能是其产生遗传毒性的一种机制,建立的方法可以很好地用于全基因组DNA总甲基化水平的检测。     

DNA羟甲基化测序技术

5-羟甲基胞嘧啶(5-hydroxymethylcytosine, 5hmC)是继5-甲基胞嘧啶(5-methylcytosine, 5mC)之后发现的第六种碱基, 已在多种哺乳动物组织和细胞中检出. 与5mC相比, 5hmC的含量更低, 但5hmC也具有非常重要的生物学功能. 已有的研究表明, 5hmC参与了染色体重新编程、基因表达的转录调控, 并在DNA去甲基化过程中发挥重要作用. 另外, 5hmC可能与特定肿瘤的发生密切相关, 有可能成为肿瘤早期诊断的生物标志物. 因此, 发展可靠、灵敏和准确的5hmC检测技术至关重要. 本综述针对DNA羟甲基化的检测及测序技术进行了简要介绍.     

基于高效液相色谱的喹噁啉类药物对刺参DNA甲基化水平的影响研究

建立了高效液相色谱/紫外法测定刺参组织全基因组DNA甲基化水平的方法,并运用此方法对喹噁啉药物处理过的刺参样品DNA甲基化水平进行分析。色谱条件为:色谱柱为ZORBAX SB-Aq(4.6 mm×250mm;5μm);柱温为30℃;检测波长为280 nm;进样量20μL;流动相为甲醇-7 mmol/L乙酸铵(7∶93),流速为1.0 mL/min。5-甲基脱氧胞苷和脱氧胞苷的质量浓度在0.05~1.0 mg/L范围内时,线性关系良好,相关系数(r)均为0.999 9。5-甲基脱氧胞苷和脱氧胞苷的检出限均为0.05 mg/L,在加标浓度为0.05,0.25,1.0 mg/L时,回收率为90.4%~100.6%,批内、批间相对标准偏差均小于4%。采用CTAB法提取刺参组织DNA,酶解后进行HPLC测定,结果表明:喹噁啉药物处理过的组织样品DNA甲基化水平低于对照组,该类药物通过改变DNA甲基化水平而影响基因的正常表达,可能是其产生遗传毒性的一种机制,建立的方法可以很好地用于全基因组DNA总甲基化水平的检测。     

老鼠Tet1蛋白能氧化单链脱氧核糖核酸上的5-甲基胞嘧啶到5-羟甲基胞嘧啶和5-羧基胞嘧啶(英文)

5-甲基胞嘧啶在哺乳动物细胞中具有广泛的作用.而它被双脱氧家族Tet蛋白氧化所得的产物5-羟甲基胞嘧啶、5-醛基胞嘧啶和5-羧基胞嘧啶也被证明在细胞发育和5-甲基胞嘧啶动态平衡调控中具有关键的作用.已有的研究结果表明,Tet蛋白能够识别双链DNA上的5-甲基胞嘧啶,并将其氧化成5-羟甲基胞嘧啶、5-醛基胞嘧啶和5-羧基胞嘧啶.我们通过质谱仪检测发现,老鼠Tet1蛋白的DNA结合结构域还能识别和氧化单链DNA上的5-甲基胞嘧啶.这一发现暗示我们,Tet蛋白家族不但具有已经发现的氧化双链DNA上5-甲基胞嘧啶的功能,还有可能作用于DNA的复制及转录,甚至具有氧化单链RNA上对应的甲基修饰碱基的能力.     

超高效液相色谱-四极杆飞行时间质谱法测定大鼠血浆中的N6-羟苄腺苷北大核心CSCD

建立了测定大鼠血浆中N6-羟苄腺苷的超高效液相色谱-四极杆飞行时间质谱(UPLC-QTOF-MS)分析方法,并应用于N6-羟苄腺苷药代动力学研究。采用Agilent ZORBAX SB-C18色谱柱(150 mm×3 mm,1.8μm)对目标物分离,以0.2%(v/v)甲酸水溶液和乙腈为流动相进行梯度洗脱;以6-苄氨基嘌呤作为内标,在电喷雾离子源正离子模式下进行定量分析。结果表明:N6-羟苄腺苷在0.625~160 ng/mL的范围内线性关系良好(r>0.99);方法的回收率在88.41%~108.26%之间;检出限达到0.1 ng/mL;日内和日间准确度(以RE计,RE=(测定浓度-加标浓度)/加标浓度×100%)均在±15%之内,精密度(以RSD计)均小于6%。该方法选择性好,灵敏度高,重现性好,结果准确,可用于N6-羟苄腺苷的血药浓度监测及药代动力学研究。     

白菜DNA甲基化水平的反相离子对高效液相色谱法研究

建立了反相离子对液相色谱测定白菜的DNA甲基化水平的方法。采用的色谱柱为HypersilBDSC18柱(200mm×4.0mm,5μm),以pH4.0的甲醇-5mmol·L-1庚烷磺酸钠-三乙胺(10:90:0.2,体积比)的混合液为流动相,UV检测器波长为273nm。通过测定DNA水样所产生的胞嘧啶和甲基胞嘧啶的含量,即可得知DNA甲基化程度。胞嘧啶和甲基胞嘧啶回收率分别为99.6%及103.3%,RSD为3.7%(日内)及5.2%(日间)。     

高效液相色谱法分析胞磷胆碱钠与葡萄糖配伍注射液在不同输液器具中的稳定性

建立高效液相色谱法测定胞磷胆碱钠与10%葡萄糖配伍注射液中5-羟甲基糠醛含量,并将其用于配伍溶液在不同输液器具中的稳定性研究。胞磷胆碱钠与10%葡萄糖配伍注射液,采用Thermo Scientific BDS Hypersil^TM C₁₈色谱柱(250 mm×4 mm,5μm)分离,柱温为40℃,以10 mmol/mL四丁基氢氧化铵-15 mmol/mL磷酸氢二钠溶液(用20%磷酸调pH值至6.0)-甲醇作为流动相进行梯度洗脱。进样体积为15μL,检测波长为284 nm。5-羟甲基糠醛在0.02～54.09μg/mL质量浓度范围内线性关系良好(r=0.999 9)。方法定量限为0.02μg/mL,检出限为0.005μg/mL。样品加标回收率为99.5～100.6%,测定结果的相对标准偏差(RSD)为0.66%。配伍溶液在聚烯烃热塑弹性体(TPE)、聚氯乙烯(PVC)材质输液器具中8 h内,5-羟甲基糠醛质量分数的相对偏差均小于0.6%(n=6),胞磷胆碱钠质量分数相对偏差均小于2.8%。该方法操作简单、灵敏度高,适用于5-羟甲基糠醛含量及其配...     

Liquid chromatographic-electrospray tandem mass spectrometric determination of bisoprolol in human plasma

An analytical method for the determination of bisoprolol in human plasma has been developed based on liquid chromatography-tandem mass spectrometry (LC-MS/MS). The analyte and internal standard (IS) diphenhydramine were cleaned up by protein precipitation with acetonitrile, reconstituted in mobile phase and separated by reversed-phase high-performance liquid chromatography (HPLC) using methanol:10 mm ammonium acetate:formic acid (70:30:0.1 v/v/v) as mobile phase. Detection was carried out by multiple reaction monitoring (MRM) on an LC-MS/MS system and was completed within 2.5 min. The assay was linear over the range 0.5-100 ng/mL with a limit of quantitation (LOQ) of 0.5 ng/mL. The intra- and inter-day precision levels were within 5.54 and 9.95%, respectively, while the accuracy was in the range 89.4-113%. This method has been utilized in a pharmacokinetic study, where healthy volunteers were treated with an oral dose of 5 mg bisoprolol.     

固相萃取-液相色谱-串联质谱法测定海水中软骨藻酸

软骨藻酸(domoic acid,DA)是一种由海洋硅藻产生的生物毒素,具有强烈的神经毒性,近海水环境中的DA严重威胁海洋渔业生物和人类健康,因此对近海水环境中的DA进行有效监测至关重要.该文基于固相萃取-液相色谱-串联质谱联用技术(SPE-LC-MS/MS),建立了适用于海水中痕量、超痕量DA的检测方法.针对近海水生...     

Liquid chromatography-electrospray tandem mass spectrometric assay suitable for quantitation of YM155, a novel small-molecule survivin suppressant, in dog plasma

This paper describes a sensitive and selective liquid chromatography with tandem mass spectrometry (LC-MS/MS) method for determination of the novel survivin suppressant YM155, 1-(2-methoxyethyl)-2-methyl-4,9-dioxo-3-(pyrazin-2-ylmethyl)-4,9-dihydro-1H-naphtho[2,3-d]imidazolium, which is developed for the treatment of solid tumors. This method uses a liquid-liquid extraction from 0.25 mL of dog plasma. LC separation was carried out on a Genesis Silica column (50 mm x 3.0 mm i.d.) at a flow-rate of 0.5 mL/min. Compounds were eluted using a mobile phase of 5 mm ammonium acetate and 0.1% formic acid in water-0.1% formic acid in acetonitrile, 17:83 (v/v). MS/MS detection was carried out with an MDS-Sciex API3000 triple quadrupole mass spectrometer in positive electrospray ionization mode. The standard curve was linear from 0.05 to 50 ng/mL (r > or = 0.9968). The lower limit of quantitation was 0.05 ng/mL. Good intra- and inter-day assay precision (within 7.4% RSD) and accuracy (within +/-12.3%) were obtained. The extraction recovery was 66.2%. The method was successfully applied to preclinical pharmacokinetic studies in dogs.     

Rapid and sensitive LC-MS/MS method for the determination of metoprolol in Beagle dog plasma with a simple protein precipitation treatment and its pharmacokinetic applications

A rapid LC-MS/MS method with good accuracy and sensitivity was developed and validated for the pharmacokinetics study of metoprolol (MP) in beagle dogs. The plasma samples were simply precipitated by methanol and then analyzed by LC-MS/MS. An Ultimate XB-C?? column (150 × 2.1 mm ID, 5 μm) was used for separation, with methanol-water containing 0.2% formic acid (65:35, v/v) as the mobile phase at a flow rate of 0.2 mL/min. Monitoring ions of MP and internal standard (hydroxypioglitazone) were m/z 268.1/115.6 and m/z 373.1/150.2, respectively. The linear range was 3.03-416.35 ng/mL with an average correlation coefficient of 0.9996, and the limit of quantification was 3.03 ng/mL. The intra- and inter-day precision was less than 15%. At low, middle and high concentrations, the recovery, the matrix effect and the accuracy was in the range of 76.06%-95.25%, 93.67%-104.19% and 95.20%-99.96% respectively. The method was applied for the pharmacokinetics study of MP tartrate tablets (50 mg). The AUC(0-t), T(max) and C(max) were respectively 919.88 ± 195.67 μg/L·h, 0.96 ± 0.33 h, 349.12 ± 78.04 ng/mL.     

A rapid and specific approach for direct measurement of donepezil concentration in human plasma by LC-MS/MS employing solid-phase extraction

A selective, rapid and simple liquid chromatography-tandem mass spectrometry (LC-MS/MS) method is described for assay of donepezil in human plasma using escitalopram as an internal standard. Chromatographic separation was achieved on a Betabasic-C(8), 5 microm, 100 x 4.6 mm column using methanol:water:formic acid (90:9.97:0.03, v/v/v) as mobile phase. Detection of donepezil and internal standard was achieved by ESI MS/MS in positive ion mode using 380.20/91.10 and 325.13/262.00 transitions, respectively. The linearity over the concentration range of 0.15-50 ng/mL for donepezil was obtained and the lower limit of quantification was 0.15 ng/mL. For each level of quality control samples, inter-day and intra-day precisions (RSD) were < or =8.92 and 10.35% and accuracy (%RE) were < or =7.33% and 9.33%, respectively. The recovery was more than 88.50% for both donepezil and internal standard by solid-phase extraction, eliminating evaporation and reconstitution steps.     

HPLC quantification of 5‐hydroxyeicosatetraenoic acid in human lung cancer tissues

A simple and cost‐effective HPLC method was established for quantification of 5‐hydroxyeicosatetraenoic acid (5‐HETE) in human lung cancer tissues. 5‐HETE from 27 patients' lung cancer tissues were extracted by solid‐phase extraction and analyzed on a Waters Symmetry C₁₈ column (4.6 × 250 mm, 5 µm) with a mobile phase consisting of methanol, 10 mm ammonium acetate, and 1 m acetic acid (70:30:0.1, v:v:v) at a flow rate of 1.0 mL/min. The UV detection wavelength was set at 240 nm. The calibration curve was linear within the concentration range from 10 to 1000 ng/mL (r² > 0.999, n = 7), the limit of detection was 1.0 ng/mL and the limit of quantitation was 10.0 ng/mL for a 100 µL injection. The relative error (%) for intra‐day accuracy was from 93.14 to 112.50% and the RSD (%) for intra‐day precision was from 0.21 to 2.60% over the concentration range 10–1000 ng/mL. By applying this method, amounts of 5‐HETE were quantitated in human lung cancer tissues from 27 human subjects. The established HPLC method was validated to be a simple, reliable and cost‐effective procedure that can be applied to conduct translational characterization of 5‐HETE in human lung cancer tissues. Copyright © 2009 John Wiley & Sons, Ltd.     

Determination of sodium cromoglycate in human plasma by liquid chromatography with tandem mass

A sensitive and selective liquid chromatography-tandem mass spectrometric (LC-MS/MS) method was developed and validated for the determination of sodium cromoglycate (SCG) in human plasma after a nasal dose of 10.4 mg sodium cromoglycate nasal spray, using pravastatin sodium as the internal standard. The method was validated over a linear range of 0.300-20.0 ng/mL. SCG and I.S. were extracted from 1.0 mL of heparinized plasma by C(18) solid-phase extraction cartridges using methanol as eluting solvent. The dried residue was reconstituted with 100 microL of mobile phase, and 10 microL was injected onto the LC-MS/MS system. Chromatographic separation was achieved on a C(18) column (250 x 4.6 mm i.d., 5 microm particle size) with a mobile phase of methanol-acetonitrile-water (containing 2 mmol/L ammonium acetate; 42.5:42.5:15, v/v/v) at a flow rate of 0.4 mL/min. The analytes were detected with a triple quad LC-MS/MS using ESI with positive ionization. Ions monitored in the multiple reaction monitoring mode were m/z 469.0 (precursor ion) to m/z 245.0 (product ion) for SCG and m/z 447.2 (precursor ion) to m/z327.1 (product ion) for pravastatin sodium (internal standard) The average recovery of SCG from human plasma was 94.88% and the lower limit of quantitation was 0.3 ng/mL. Results from a 3-day validation study demonstrated excellent precision and accuracy across the calibration range of 0.3-20 ng/mL. The method was successfully applied to the pharmacokinetic study of SCG in healthy Chinese volunteers. Copyright (c) 2008 John Wiley & Sons, Ltd.     

Simultaneous determination of mifepristone and monodemethyl-mifepristone in human plasma by liquid chromatography-tandem mass spectrometry method using levonorgestrel as an internal standard: application to a pharmacokinetic study

A rapid and sensitive liquid chromatography/tandem mass spectrometry (LC-MS/MS) method was developed and validated to simultaneously determine mifepristone and monodemethyl-mifepristone in human plasma using levonorgestrel as the internal standard (IS). After solid-phase extraction of the plasma samples, mifepristone, monodemethyl-mifepristone and the IS were subjected to LC-MS/MS analysis using electro-spray ionization (ESI) in the multiple reaction monitoring (MRM) mode. Chromatographic separation was performed on an XTERRA MS C(18) column (150 x 2.1 mm i.d., 5 microm). The method had a chromatographic run time of 4.5 min and linear calibration curves over the concentration ranges of 5-2000 ng/mL for mifepristone and monodemethyl-mifepristone. The recoveries of the method were found to be 94.5-103.7% for mifepristone and 70.7-77.3% for monodemethyl-mifepristone. The method had a lower limit of quantification (LLOQ) of 5.0 ng/mL and a lower limit of detection (LOD) of 1.0 ng/mL for both mifepristone and monodemethyl-mifepristone. The intra- and inter-batch precision was less than 15% for all quality control samples at concentrations of 10, 100 and 1000 ng/mL. These results indicate that the method was efficient with a short run time (4.5 min) and acceptable accuracy, precision and sensitivity. The validated LC-MS/MS method was successfully used in a pharmacokinetic study in healthy female volunteers after oral administration of 25 mg mifepristone tablet.